Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

Portfolio

Loading...
Select Portfolio and Asset Combination for Display on Market Band
Select Portfolio
Select Asset Class
Show More
Download ET MARKETS APP

Get ET Markets in your own language

DOWNLOAD THE APP NOW

+91

CHOOSE LANGUAGE

ENG

  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা
  • KAN - ಕನ್ನಡ
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
Drag according to your convenience
ET NOW RADIO
ET NOW
TIMES NOW

Netmeds raises $14 million from Tanncam, Sistema Asia Fund

PTI|
Updated: Oct 31, 2017, 02.51 PM IST
0Comments
NEW DELHI: Online pharmacy Netmeds has raised $14 million (over Rs 90 crore) in the latest round of funding from Cambodian investment holding company Tanncam and venture firm Sistema Asia Fund.

Tanncam and Sistema will join early investors investment bank MAPE and OrbiMed Asia, along with Pradeep Dadha and his family, as stakeholders in the company, Netmeds said in a statement.

Netmeds CEO Pradeep Dadha said, "We believe that this round of funding reflects a renewed confidence in the industry and its future, brought about by both GST and the government's release of the draft of rules governing online pharmacies."

The investment will be used to continue to build upon Netmeds' consumer base and expand its reach to more locations in the country, he added.

"Netmeds is changing the paradigm in the pharma market in India and we strongly believe in the merits of the investment," Tanncam CEO Anthony Galliano said on the development.

"We work with many start-ups and young entrepreneurs, but Netmeds is unique among them because it is led by such a strong and seasoned leadership," Sistema Asia Fund MD Kirill Kozhevnikov said.

Netmeds offers customers ease of shopping for medicines and other healthcare products through its online portal, mobile application and customer care call centre.
0Comments
Comments
Add Your Comments

Loading
Please wait...